Rockley Photonics Holdings Limited develops and supplies silicon photonics in the United Kingdom and internationally. It offers a platform, which comprises photonic integrated circuits in silicon with integrated III-V devices; application-specific electronic integrated circuits; photonic and electronic co-packaging, which are supported by and coupled with biosensing algorithms, artificial intelligence, cloud analytics, firmware/software, system architecture, and hardware design. The company also provides a biosensing platform for consumer wellness, long-term health trend monitoring, patient monitoring, early disease detection, nutrition management, and treatment of certain chronic diseases. Rockley Photonics Holdings Limited was founded in 2013 and is headquartered in Altrincham, the United Kingdom.

Rockley Photonics Holdings Limited

Rockley Photonics develops wearable health sensing technologies, focusing on non-invasive monitoring of various health metrics, including glucose and blood pressure, using silicon photonics.

NYSE:RKLY

Rockley Photonics

Last Close

0.19

23/01 21:00

PE Ratio

−0.11

PFCF: -